Get the Stockscreener App
81.24
0.89%
-0.73
After Hours:
81.24
Lemaitre Vascular Inc stock is traded at $81.24, with a volume of 107.24K.
It is down -0.89% in the last 24 hours and down -2.18% over the past month.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.
See More
Previous Close:
$81.97
Open:
$81.35
24h Volume:
107.24K
Relative Volume:
0.67
Market Cap:
$1.84B
Revenue:
$213.03M
Net Income/Loss:
$41.32M
P/E Ratio:
44.39
EPS:
1.83
Net Cash Flow:
$33.49M
1W Performance:
+0.58%
1M Performance:
-2.18%
6M Performance:
-16.19%
1Y Performance:
-6.50%
1-Day Range:
$80.05
$81.94
1-Week Range:
$80.05
$83.46
52-Week Range:
$71.42
$109.58
Lemaitre Vascular Inc Stock (LMAT) Company Profile
Name
Lemaitre Vascular Inc
Sector
Industry
Phone
781-221-2266
Address
63 SECOND AVENUE, BURLINGTON, MA
Compare LMAT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LMAT
Lemaitre Vascular Inc
|
81.24 | 1.85B | 213.03M | 41.32M | 33.49M | 1.83 |
|
ISRG
Intuitive Surgical Inc
|
481.09 | 179.42B | 9.15B | 2.61B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
178.25 | 52.03B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
87.55 | 44.11B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
271.94 | 40.68B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
239.26 | 17.92B | 2.90B | 467.20M | 306.90M | 6.37 |
Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-28-25 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Feb-28-25 | Downgrade | Oppenheimer | Outperform → Perform |
| Feb-13-25 | Initiated | Wells Fargo | Equal Weight |
| Oct-15-24 | Initiated | Cantor Fitzgerald | Neutral |
| Aug-02-24 | Resumed | Lake Street | Buy |
| May-31-24 | Resumed | ROTH MKM | Buy |
| Apr-26-24 | Upgrade | Stifel | Hold → Buy |
| Feb-06-24 | Resumed | KeyBanc Capital Markets | Sector Weight |
| Oct-23-23 | Initiated | JMP Securities | Mkt Outperform |
| Sep-06-23 | Initiated | Oppenheimer | Outperform |
| Aug-03-23 | Downgrade | Jefferies | Buy → Hold |
| May-03-23 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Oct-28-22 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Sep-16-21 | Initiated | Jefferies | Buy |
| Feb-12-21 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Mar-16-20 | Upgrade | Sidoti | Neutral → Buy |
| Oct-24-19 | Downgrade | First Analysis Sec | Strong Buy → Outperform |
| Oct-24-19 | Upgrade | Lake Street | Hold → Buy |
| Oct-14-19 | Upgrade | First Analysis Sec | Outperform → Strong Buy |
| Jul-25-19 | Reiterated | Barrington Research | Outperform |
| Jul-25-19 | Upgrade | First Analysis Sec | Neutral → Outperform |
| Oct-08-18 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Oct-08-18 | Upgrade | ROTH Capital | Neutral → Buy |
| Jun-08-18 | Resumed | ROTH Capital | Buy |
| Apr-26-18 | Downgrade | Stifel | Buy → Hold |
| Apr-26-18 | Upgrade | The Benchmark Company | Hold → Buy |
| Oct-27-17 | Downgrade | First Analysis Sec | Overweight → Equal-Weight |
| Oct-27-17 | Downgrade | The Benchmark Company | Buy → Hold |
| Jul-10-17 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jul-10-17 | Downgrade | The Benchmark Company | Buy → Hold |
| Mar-21-17 | Initiated | First Analysis Sec | Overweight |
| Feb-22-17 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Sep-22-16 | Downgrade | Sidoti | Buy → Neutral |
| Jul-28-16 | Reiterated | Barrington Research | Outperform |
| Feb-25-16 | Reiterated | Barrington Research | Outperform |
View All
Lemaitre Vascular Inc Stock (LMAT) Latest News
Key metrics from LeMaitre Vascular Inc.’s quarterly dataStock Market Trend and Pattern Analysis - Newser
Real time social sentiment graph for LeMaitre Vascular Inc.AI Pattern Recognition and Trade Prediction - Newser
Comparing LeMaitre Vascular Inc. in custom built stock radarsMarket Liquidity and Price Flow Analysis - Newser
Backtesting results for LeMaitre Vascular Inc. trading strategiesSwing Candidate List with Trade Cues - Newser
Published on: 2025-07-31 05:30:51 - Newser
Why LeMaitre Vascular Inc. stock attracts strong analyst attentionInvestment Roadmap for High Potential Stocks - Newser
Forecasting LeMaitre Vascular Inc. price range with options dataTrading Watchlist with Real Time Filters - Newser
Published on: 2025-07-30 21:47:16 - Newser
Reversal indicators forming on LeMaitre Vascular Inc. stockInvestment Strategy Designed for Capital Protection - metal.it
LeMaitre Vascular (LMAT) to Release Earnings on Tuesday - MarketBeat
Ranking LeMaitre Vascular Inc. among high performing stocks via toolsTechnical Chart Summary for Momentum Stocks - Newser
How Efficient Is LeMaitre Vascular Inc. at Controlling Operating CostsDaily Market Entry Strategy with Tools - Newser
Applying Wyckoff theory to LeMaitre Vascular Inc. stockSmart Entry Signals for Active Traders - Newser
LeMaitre Vascular Inc. Approaches Psychological Resistance LevelQuick Gain Stock Watch With Indicators Reviewed - metal.it
Using data tools to time your LeMaitre Vascular Inc. exitSmart Money Strategy for Growth Stocks - Newser
Published on: 2025-07-29 04:48:22 - Newser
Detecting support and resistance levels for LeMaitre Vascular Inc. Intraday Price Forecast Using Volume Models - Newser
JMP reiterates Market Outperform rating on LeMaitre Vascular stock ahead of earnings - Investing.com Australia
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Sold by Wakefield Asset Management LLLP - MarketBeat
How strong is LeMaitre Vascular Inc. company’s balance sheetFree Stock Index Interpretation - jammulinksnews.com
What is LeMaitre Vascular Inc. company’s growth strategyStrongest growth potential - jammulinksnews.com
What is the dividend policy of LeMaitre Vascular Inc. stockAchieve rapid portfolio growth with expert guidance - jammulinksnews.com
How LeMaitre Vascular Inc. stock performs during market volatilityFree Stock Market Trend Analysis - Newser
Victory Capital Management Inc. Has $6.70 Million Stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Receives Market Perform Rating from Barrington Research - MarketBeat
Can LeMaitre Vascular Inc. stock recover from recent declineHigh-margin investment plays - jammulinksnews.com
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Given Average Rating of "Hold" by Analysts - MarketBeat
Analysts Set LeMaitre Vascular, Inc. (NASDAQ:LMAT) Target Price at $97.83 - Defense World
What risks could impact LeMaitre Vascular Inc. stock performanceFastest return on investment - jammulinksnews.com
What analysts say about LeMaitre Vascular Inc. stockAccelerated capital growth - PrintWeekIndia
What makes LeMaitre Vascular Inc. stock price move sharplyReal Time Breakout Tracking - Newser
LeMaitre Vascular Inc. Stock Analysis and ForecastRapid wealth accumulation - PrintWeekIndia
New York State Common Retirement Fund Sells 1,296 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World
Bank of New York Mellon Corp Trims Stock Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
Lemaitre Vascular Inc Stock (LMAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.22%
22.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):